Acute hepatitis B 14 years after the implementation of universal vaccination in Italy: Areas of improvement and emerging challenges

Clinical Infectious Diseases

Volumn 46, Issue 6, 2008, Pages 868-875

  Mele, Alfonso ^a   Tosti, Maria Elena ^a   Mariano, Andrea ^b   Pizzuti, Renato ^d   Ferro, Antonio ^e   Borrini, Bianca ^f   Zotti, Carla ^g   Lopalco, Pierluigi ^h   Curtale, Filippo ^c   Balocchini, Emanuela ⁱ   Spada, Enea ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b NATIONAL INSTITUTE FOR INFECTIOUS DISEASES L SPALLANZANI   (Italy)

^c Public Health Agency of Lazio Region   (Italy)

^d Regional Health Authority   (Italy)

^e Service of Public Health and Screening   (Italy)

^f Regional Health Authority   (Italy)

^g UNIVERSITY OF TURIN   (Italy)

^h UNIVERSITY OF BARI   (Italy)

ⁱ Regional Health Authority   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B VACCINE;

ACUTE HEPATITIS; ADOLESCENT; ADULT; ARTICLE; BLOOD TRANSFUSION; CONTROLLED STUDY; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; IMMUNIZATION; INFECTION RISK; ITALY; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; UNSAFE SEX; VACCINATION; ACUTE DISEASE; CASE CONTROL STUDY; CHILD; HEALTH SURVEY; IMMUNOLOGY; INCIDENCE; INFANT; METHODOLOGY; NEWBORN; PRESCHOOL CHILD; PREVENTIVE HEALTH SERVICE; PUBLIC HEALTH; RISK FACTOR;

ACUTE DISEASE; ADOLESCENT; ADULT; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; FEMALE; HEPATITIS B; HEPATITIS B VACCINES; HEPATITIS B VIRUS; HUMANS; IMMUNIZATION PROGRAMS; INCIDENCE; INFANT; INFANT, NEWBORN; ITALY; MALE; NATIONAL HEALTH PROGRAMS; POPULATION SURVEILLANCE; RISK FACTORS; VACCINATION;

EID: 40749091277     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/528687     Document Type: Article

References (41)

1. World Health Organization. WHO/CDS/CSR/LYO/2002.2: hepatitis B. Available at: http://www.who.int/emc. Accessed 17 July 2007.
2. Shepard CW, Simard EP, Finelli L, Fiore AE, Bell BP. Hepatitis B virus infection: epidemiology and vaccination. Epidemiol Rev 2006; 28:112-25.
3. Custer B, Sullivan SD, Hazlet TK, Iloeje U, Veenstra DL, Kowdley KV. Global epidemiology of hepatitis B virus. J Clin Gastroenterol 2004; 38(Suppl 10):158-68.
4. Lavanchy D. Worldwide epidemiology of HBV infection, disease burden, and vaccine prevention. J Clin Virol 2005; 34(Suppl 1):1-3.
5. Perz JF, Armstrong GL, Farrington LA, Hutin YJ, Bell BP. The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide. J Hepatol 2006; 45:529-38.
6. Hauri AM, Armstrong GL, Hutin YJ. The global burden of disease attributable to contaminated injections given in health care settings. Int J STD AIDS 2004; 15:7-16.
7. Williams R. Global challenges in liver disease. Hepatology 2006; 44:521-6.
8. Giacchino R, Zancan L, Vajro P, et al. Hepatitis B virus infection in native versus immigrant or adopted children in Italy following the compulsory vaccination. Infection 2001; 29:188-91.
9. Alter HJ, Houghton M. Hepatitis C virus and eliminating post-transfusion hepatitis. Nat Med 2000; 6:1082-6.
10. Comanor L, Holland P. Hepatitis B virus blood screening: unfinished agendas. Vox Sang 2006; 91:1-12.
11. Ouattara H, Siransy-Bogui L, Fretz C, et al. Residual risk of HIV, HVB and HCV transmission by blood transfusion between 2002 and 2004 at the Abidjan National Blood Transfusion Center. Transfus Clin Biol 2006; 13:242-5.
12. Shang G, Seed CR, Wang F, Nie D, Farrugia A. Residual risk of transfusion-transmitted viral infections in Shenzhen, China, 2001 through 2004. Transfusion 2007; 47:529-39.
13. World Health Organization. Hepatitis B fact sheet. No 204 (revised October 2000). Geneva: World Health Organization, 2000.
14. Mele A, Rosmini F, Zampieri A, Gill ON. Integrated epidemiological system for acute viral hepatitis in Italy (SEIEVA): description and preliminary results. Eur J Epidemiol 1986; 2:300-4.
15. Hosmer DW, Lemeshow S. Applied logistic regression. New York: Wiley Intersciences, 2000.
16. StataCorp. Stata statistical software: release 8.0. College Station, TX: Stata, 2003.
17. Stroffolini T, Mele A, Tosti ME, et al. The impact of the hepatitis B mass immunisation campaign on the incidence and risk factors of acute hepatitis B in Italy. J Hepatol 2000; 33:980-5.
18. D'Argenio P, Esposito D, Mele A, et al. Decline in the exposure to hepatitis A and B infections in children in Naples, Italy. Public Health 1989; 103:385-9.
19. Pasquini P, Kahn HA, Pileggi D, et al. Prevalence of hepatitis B markers in Italy. Am J Epidemiol 1983; 118:699-709.
20. D'Amelio R, Matricardi PM, Biselli R, et al. Changing epidemiology of hepatitis B in Italy: public health implications. Am J Epidemiol 1992; 135:1012-8.
21. Zanetti AR. Update on hepatitis B vaccination in Italy 10 years after its implementation. Vaccine 2001; 19:2380-3.
22. Stroffolini T, Cialdea L, Tosti ME, et al. Vaccination campaign against hepatitis B for 12 year-old subjects in Italy. Vaccine 1997; 15:583-5.
23. Stampi S, Ricci R, Ruffilli I, Zanetti F. Compulsory and recommended vaccination in Italy: evaluation of coverage and non-compliance between 1998-2002 in Northern Italy. BMC Public Health 2005; 5:42.
24. Mele A, Tancredi F, Romanò L, et al. Effectiveness of hepatitis B vaccination in babies born to hepatitis B surface antigen-positive mothers in Italy. J Infect Dis 2001; 184:905-8.
25. Kubba AK, Taylor P, Graneek B, Strobel S. Non-responders to hepatitis B vaccination: a review. Commun Dis Public Health 2003; 6:106-12.
26. Allain JP. Occult hepatitis B virus infection: implications in transfusion. Vox Sang 2004; 86:83-91.
27. Tosti ME, Solinas S, Prati D, et al. An estimate of the current risk of transmitting blood-borne infections through blood transfusion in Italy. Br J Haematol 2002; 117:215-9.
28. Velati C, Fomiatti L, Romanò L, Baruffi L, Zanetti A. NAT screening for HCV, HIV and HBV on blood donations in Italy [poster 137]. In: Program and abstracts of the 39th International Congress of the International Society of Blood Transfusion (Cape Town, South Africa). Amsterdam: International Society of Blood Transfusion, 2006:30.
29. Zanetti AR, Romanò L, Zappa A, Velati C. Changing patterns of hepatitis B infection in Italy and NAT testing for improving the safety of blood supply. J Clin Virol 2006; 36(Suppl 1):51-5.
30. Soldan K, Ramsay M, Collins M. Acute hepatitis B infection associated with blood transfusion in England and Wales, 1991-7: review of database. BMJ 1999; 9:318-95.
31. Roth WK, Weber M, Petersen D, et al. NAT for HBV and anti-HBc testing increase blood safety. Transfusion 2002; 42:869-75.
32. Satake M, Taira R, Yugi H, et al. Infectivity of blood components with low hepatitis B virus DNA levels identified in a lookback program. Transfusion 2007; 47:1197-205.
33. Mele A, Spada E, Sagliocca L, et al. Risk of parenterally transmitted hepatitis following exposure to surgery or other invasive procedures: results from the hepatitis surveillance system in Italy. J Hepatol 2001;35:284-9.
34. Quaglio G, Lugoboni F, Mezzelani P, Des Jarlais DC, Lechi A. Hepatitis vaccination among drug users. Vaccine 2006; 24:2702-9.
35. Wright NM, Campbell TL, Tompkins CN. Comparison of conventional and accelerated hepatitis B immunisation schedules for homeless drug users. Commun Dis Public Health 2002; 5:324-6.
36. Rogers N, Lubman DI. An accelerated hepatitis B vaccination schedule for young drug users. Aust N Z J Public Health 2005; 29:305-7.
37. Stroffolini T, Bianco E, Szklo A, et al. Factors affecting the compliance of the antenatal hepatitis B screening programme in Italy. Vaccine 2003; 2:1246-9.
38. Macpherson DW, Gushulak BD, Macdonald L. Health and foreign policy: influences of migration and population mobility. Bull World Health Organ 2007; 85:200-6.
39. Bianco E, Stroffolini T, Spada E, et al. Case fatality rate of acute viral hepatitis in Italy: 1995-2000: an update. Dig Liver Dis 2003; 35:404-8.
40. Liaw YF, Yeh CT, Tsai SL. Impact of acute hepatitis B virus superinfection on chronic hepatitis C virus infection. Am J Gastroenterol 2000; 95:2978-80.
41. Mele A, Mariano A, Tosti ME, et al. Acute hepatitis delta virus infection in Italy: incidence and risk factors after the introduction of the universal anti-hepatitis B vaccination campaign. Clin Infect Dis 2007; 44:17-24.